Guidant Newswire

Guidant Newswire

Comprehensive Real-Time News Feed for Guidant.

Results 1 - 20 of 203 in Guidant

  1. Boston Scientific Co. (BSX) Stock Rating Reaffirmed by Piper JaffrayRead the original story w/Photo

    Thursday Jun 23 | Daily Political

    's stock had its "overweight" rating reiterated by investment analysts at Piper Jaffray in a report issued on Tuesday. They presently have a $26.00 price objective on the stock.

    Comment?

  2. Boston Scientific Co. (BSX) Stock Rating Reaffirmed by Piper JaffrayRead the original story w/Photo

    Thursday Jun 23 | Daily Political

    's stock had its "overweight" rating reiterated by Piper Jaffray in a research report issued to clients and investors on Tuesday. They currently have a $26.00 price objective on the stock.

    Comment?

  3. Boston Scientific Co. (BSX) Given "Overweight" Rating at Piper JaffrayRead the original story w/Photo

    Tuesday Jun 21 | AmericanBankingNews.com

    's stock had its "overweight" rating reiterated by investment analysts at Piper Jaffray in a report issued on Tuesday. They currently have a $26.00 price target on the stock.

    Comment?

  4. Mike Sherman '88 Named President & CEO of EndocyteRead the original story w/Photo

    Monday Jun 20 | WGRE-FM Greencastle

    ... and bringing our medicines to patients." (at left: Mike Sherman in 1986) Sherman came to Endocyte in 2006 from Guidant Corporation, where he was vice president of finance and strategic planning. He also serves on the board of directors at Mead ...

    Comment?

  5. Endocyte Co-Founder Resigns Effective Immediately as CEO, New Leader NamedRead the original story

    Sunday Jun 19 | BioSpace

    ... Mr. Sherman served in various executive roles, most recently as vice president of finance and strategic planning of Guidant Corporation, a cardiovascular device manufacturer acquired by Boston Scientific Corporation. He also serves on the Board of ...

    Comment?

  6. Boston Scientific Co. (BSX) Rating Reiterated by Leerink SwannRead the original story w/Photo

    Friday Jun 17 | AmericanBankingNews.com

    's stock had its "buy" rating restated by research analysts at Leerink Swann in a note issued to investors on Friday. They currently have a $27.50 target price on the stock, up from their prior target price of $25.50.

    Comment?

  7. Boston Scientific Co. (BSX) Shares Sold by TimesSquare Capital Management LLCRead the original story w/Photo

    Friday Jun 10 | Daily Political

    TimesSquare Capital Management LLC cut its position in Boston Scientific Co. by 2.3% during the first quarter, Holdings Channel reports.

    Comment?

  8. 's Top InitiationsRead the original story w/Photo

    Thursday Jun 9 | Benzinga

    Guggenheim Securities initiated coverage on Boston Scientific Corporation with a Buy rating. Boston Scientific shares rose 0.75 percent to close at $22.80 on Wednesday.

    Comment?

  9. BlackRock Japan Co. Ltd Has $31,550,000 Stake in Boston Scientific Co.Read the original story w/Photo

    Thursday Jun 9 | Daily Political

    BlackRock Japan Co. Ltd boosted its position in shares of Boston Scientific Co. by 0.7% during the first quarter, Holdings Channel reports.

    Comment?

  10. Boston Scientific restructures, annual operating expenses to be cut as much as $150M by 2020Read the original story w/Photo

    Thursday Jun 9 | Seeking Alpha

    With the aim of building on its progress in executing its long-term growth strategies, Boston Scientific announces a global restructuring program that should reduce annual pre-tax operating expenses by $115M - $150M by 2020. The company intends to reinvest the savings into its growth initiatives.

    Comment?

  11. Boston Scientific Co. (BSX) Receives New Coverage from Analysts at GuggenheimRead the original story w/Photo

    Thursday Jun 9 | Daily Political

    In other news, SVP Kevin J. Ballinger sold 16,705 shares of the stock in a transaction that occurred on Friday, March 11th. The shares were sold at an average price of $18.00, for a total transaction of $300,690.00.

    Comment?

  12. Boston Scientific Announces Restructuring Program to Support Long-Term Growth and InnovationRead the original story

    Wednesday Jun 8 | Freshnews

    Boston Scientific Corporation today announced a global restructuring program to build on the progress the company has made in executing long-term growth strategies and bringing differentiated value and innovation to patients and healthcare systems. The program is focused on developing global commercialization, technology and manufacturing capabilities in key growth markets, continuing implementation of the company's plant network optimization strategy and expanding operational efficiencies in support of the company's operating income margin goals.

    Comment?

  13. Boston Scientific announces 'global restructuring' but gives few detailsRead the original story w/Photo

    Wednesday Jun 8 | Business Journal

    Riding a wave of recent success, the state's biggest medical device firm, Boston Scientific Corp., announced a "global restructuring program" Wednesday evening, but gave few details.

    Comment?

  14. Boston Scientific Co. (BSX) Now Covered by GuggenheimRead the original story w/Photo

    Wednesday Jun 8 | AmericanBankingNews.com

    Several hedge funds and institutional investors have modified their holdings of the company. California State Teachers Retirement System boosted its position in shares of Boston Scientific by 1.6% in the fourth quarter.

    Comment?

  15. Guggenheim Begins Coverage on Boston Scientific Co.Read the original story w/Photo

    Wednesday Jun 8 | AmericanBankingNews.com

    Several hedge funds and institutional investors have recently modified their holdings of the company. Commonwealth Equity Services Inc raised its position in shares of Boston Scientific by 0.5% in the first quarter.

    Comment?

  16. BlackRock Fund Advisors Increases Stake in Boston Scientific Co.Read the original story w/Photo

    Wednesday Jun 8 | Daily Political

    BlackRock Fund Advisors boosted its stake in shares of Boston Scientific Co. by 0.0% during the first quarter, Holdings Channel reports.

    Comment?

  17. Boston Scientific Co. (BSX) Stake Boosted by BlackRock Institutional Trust Company N.A.Read the original story w/Photo

    Wednesday Jun 8 | Daily Political

    BlackRock Institutional Trust Company N.A. boosted its position in shares of Boston Scientific Co. by 0.6% during the first quarter, according to its most recent 13F filing with the SEC.

    Comment?

  18. Family of allergic child sues Panera for putting peanut butter in grilled cheese sandwichRead the original story w/Photo

    Sunday Jun 5 | Boston.com

    In a case reflecting the growing tensions around food allergies, the family of a 6-year-old Natick girl with a serious peanut allergy filed suit last week in Middlesex Superior Court against Panera and a group of Panera franchises in New England. The suit alleges negligence stemming from an incident in which the grilled cheese the girl ordered came with a large dollop of peanut butter inside, leading to her hospitalization.

    Comment?

  19. Traders Buy Boston Scientific Co. (BSX) on Weakness After Insider SellingRead the original story w/Photo

    Friday Jun 3 | Daily Political

    Traders purchased shares of Boston Scientific Co. on weakness during trading on Friday following insider selling activity.

    Comment?

  20. Boston Scientific Co. (NYSE:BSX) Given Average Recommendation of "Buy" by BrokeragesRead the original story w/Photo

    Monday May 30 | Daily Political

    Shares of Boston Scientific Co. have received a consensus rating of "Buy" from the twenty-five analysts that are currently covering the stock.

    Comment?